Genipin-cross-linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications.

In this study, genipin-cross-linked collagen/chitosan biodegradable porous scaffolds were prepared for articular cartilage regeneration. The influence of chitosan amount and genipin concentration on the scaffolds physicochemical properties was evaluated. The morphologies of the scaffolds were characterized by scanning electron microscope (SEM) and cross-linking degree was investigated by ninhydrin assay. Additionally, the mechanical properties of the scaffolds were assessed under dynamic compression. To study the swelling ratio and the biostability of the collagen/chitosan scaffold, in vitro tests were also carried out by immersion of the scaffolds in PBS solution or digestion in collagenase, respectively. The results showed that the morphologies of the scaffolds underwent a fiber-like to a sheet-like structural transition by increasing chitosan amount. Genipin cross-linking remarkably changed the morphologies and pore sizes of the scaffolds when chitosan amount was less than 25%. Either by increasing the chitosan ratio or performing cross-linking treatment, the swelling ratio of the scaffolds can be tailored. The ninhydrin assay demonstrated that the addition of chitosan could obviously increase the cross-linking efficiency. The degradation studies indicated that genipin cross-linking can effectively enhance the biostability of the scaffolds. The biocompatibility of the scaffolds was evaluated by culturing rabbit chondrocytes in vitro. This study demonstrated that a good viability of the chondrocytes seeded on the scaffold was achieved. The SEM analysis has revealed that the chondrocytes adhered well to the surface of the scaffolds and contacted each other. These results suggest that the genipin-cross-linked collagen/chitosan matrix may be a promising formulation for articular cartilage scaffolding.

[1]  I. Martin,et al.  Differential cartilaginous tissue formation by human synovial membrane, fat pad, meniscus cells and articular chondrocytes. , 2007, Osteoarthritis and cartilage.

[2]  R. Reis,et al.  Novel genipin-cross-linked chitosan/silk fibroin sponges for cartilage engineering strategies. , 2008, Biomacromolecules.

[3]  Rui L. Reis,et al.  Biodegradable Systems in Tissue Engineering and Regenerative Medicine , 2004 .

[4]  A. Ahluwalia,et al.  Genipin-crosslinked chitosan/gelatin blends for biomedical applications , 2008, Journal of materials science. Materials in medicine.

[5]  H. Sung,et al.  Synthesis and characterization of a novel chitosan‐based network prepared using naturally occurring crosslinker , 2000 .

[6]  J. Mansour,et al.  Repair of large full-thickness articular cartilage defects with allograft articular chondrocytes embedded in a collagen gel. , 1998, Tissue engineering.

[7]  R. Reis,et al.  Mechanical Characterization of Biomaterials , 2004 .

[8]  J. Mano.  Viscoelastic properties of chitosan with different hydration degrees as studied by dynamic mechanical analysis. , 2008, Macromolecular bioscience.

[9]  C B Sledge,et al.  Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. , 1997, Journal of biomedical materials research.

[10]  Tom Minas,et al.  Current concepts in the treatment of articular cartilage defects. , 1997, Orthopedics.

[11]  H. Sung,et al.  Biocompatibility study of a biological tissue fixed with a naturally occurring crosslinking reagent. , 1998, Journal of biomedical materials research.

[12]  R. L. Reis,et al.  A cartilage tissue engineering approach combining starch-polycaprolactone fibre mesh scaffolds with bovine articular chondrocytes , 2007, Journal of materials science. Materials in medicine.

[13]  A Oosterhof,et al.  Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. , 1999, Biomaterials.

[14]  H. Sung,et al.  Feasibility study of a natural crosslinking reagent for biological tissue fixation. , 1998, Journal of biomedical materials research.

[15]  H. Sung,et al.  Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies. , 2003, Journal of biomedical materials research. Part A.

[16]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[17]  I. Yannas,et al.  Antigenicity and immunogenicity of collagen. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[18]  Zhen Li,et al.  Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites is modulated by frequency and amplitude of dynamic compression and shear stress. , 2010, Tissue engineering. Part A.

[19]  S. Nishimura,et al.  Feasibility of polysaccharide hybrid materials for scaffolds in cartilage tissue engineering: evaluation of chondrocyte adhesion to polyion complex fibers prepared from alginate and chitosan. , 2004, Biomacromolecules.

[20]  Lie Ma,et al.  Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. , 2003, Biomaterials.

[21]  R. Reis,et al.  Osteochondral defects: present situation and tissue engineering approaches , 2007, Journal of tissue engineering and regenerative medicine.

[22]  R. H. Davis,et al.  The effect of gamma irradiation on injectable human amnion collagen. , 1989, Journal of biomedical materials research.

[23]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[24]  Rui L Reis,et al.  Morphology, mechanical characterization and in vivo neo-vascularization of chitosan particle aggregated scaffolds architectures. , 2008, Biomaterials.

[25]  J. F. Woessner,et al.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. , 1961, Archives of biochemistry and biophysics.

[26]  Min Jung Song,et al.  Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide cross-linking. , 2002, Biomaterials.

[27]  Ick Chan Kwon,et al.  Effects of the controlled-released TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. , 2004, Biomaterials.

[28]  Hsing-Wen Sung,et al.  In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. , 2002, Biomaterials.

[29]  E. J. Miller,et al.  Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment. , 1995, Journal of biomedical materials research.

[30]  Farshid Guilak,et al.  A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. , 2007, Nature materials.

[31]  Rui L Reis,et al.  Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells. , 2006, Biomaterials.

[32]  R. Reis,et al.  Preparation and characterisation in simulated body conditions of glutaraldehyde crosslinked chitosan membranes , 2004, Journal of materials science. Materials in medicine.

[33]  C. Kennedy,et al.  Molecular interactions in collagen and chitosan blends. , 2004, Biomaterials.

[34]  Robert M Nerem,et al.  Mechanical compression alters gene expression and extracellular matrix synthesis by chondrocytes cultured in collagen I gels. , 2002, Biomaterials.

[35]  R. Reis,et al.  Effect of solvent-dependent viscoelastic properties of chitosan membranes on the permeation of 2-phenylethanol , 2009 .

[36]  J. Ong,et al.  The effect of cross-linking of chitosan microspheres with genipin on protein release , 2007 .

[37]  R. Reis,et al.  Dynamic Mechanical Analysis in Polymers for Medical Applications , 2002 .

[38]  J. Vacanti,et al.  Tissue engineering. , 1993, Science.

[39]  D. Zukor,et al.  Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). , 2000, Arthritis and rheumatism.

[40]  R. Reis,et al.  Chitosan particles agglomerated scaffolds for cartilage and osteochondral tissue engineering approaches with adipose tissue derived stem cells , 2006 .

[41]  Dietmar W Hutmacher,et al.  Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits. , 2006, Biomaterials.

[42]  J. Mano,et al.  Viscoelastic Behavior of Poly(methyl methacrylate) Networks with Different Cross-Linking Degrees , 2004 .

[43]  Ann L. Johnson,et al.  Chitosan scaffolds: interconnective pore size and cartilage engineering. , 2006, Acta biomaterialia.

[44]  R. Reis,et al.  Dynamic mechanical behavior of starch-based scaffolds in dry and physiologically simulated conditions: effect of porosity and pore size. , 2008, Acta biomaterialia.

[45]  Makarand V Risbud,et al.  Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. , 2005, Biomaterials.

[46]  H. Sung,et al.  Mechanical properties of a porcine aortic valve fixed with a naturally occurring crosslinking agent. , 1999, Biomaterials.

[47]  Ling Qin,et al.  Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold. , 2006, Biomaterials.

[48]  Jia-cong Shen,et al.  Thermal dehydration treatment and glutaraldehyde cross-linking to increase the biostability of collagen–chitosan porous scaffolds used as dermal equivalent , 2003, Journal of biomaterials science. Polymer edition.

[49]  Yugyung Lee,et al.  Biomedical applications of collagen. , 2001, International journal of pharmaceutics.